Introduction

The global healthcare landscape changed dramatically during the COVID-19 crisis. Mental health became a primary concern as lockdowns and social isolation took a toll on the population. A recent systematic review published in BJPsych Open examined antidepressant prescribing trends among adults in the UK and the Republic of Ireland. This study provides critical insights into how medication patterns evolved during and after the peak of the pandemic.

Understanding Antidepressant Prescribing Trends

Researchers conducted an extensive search across six major databases, including MEDLINE and Scopus. They identified ten high-quality studies that tracked prescription data between 2020 and 2022. The results showed that antidepressant prescribing trends continued to rise steadily throughout the pandemic. This increase generally aligns with the trends observed in the years leading up to 2020. However, the data also revealed a sharp, brief decline in prescriptions between March and May 2020. This likely occurred because of the sudden onset of lockdown measures and reduced access to routine GP consultations.

Demographic Shifts and Medication Types

The review highlighted significant differences across various demographic groups. For instance, women consistently showed higher rates of antidepressant use compared to men. Middle-aged adults represented the most common age group receiving these medications. Furthermore, the study categorized prescriptions by drug type, focusing on selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), and tricyclic antidepressants. Despite the overall increase, the researchers noted that future work must evaluate whether these treatment decisions were always clinically appropriate given the complex psychosocial stressors of the time.

Addressing Future Mental Health Demands

The persistent growth in antidepressant use suggests that mental health services face mounting pressure. Consequently, healthcare providers must prepare for sustained demand for psychological and pharmacological support. While medication is a vital tool, experts emphasize the need to explore the psychosocial factors influencing these choices. Understanding these drivers will help clinicians in both the UK and India refine their approach to mental health care in a post-pandemic world.

Frequently Asked Questions

Did antidepressant use increase significantly during the pandemic?

Yes, most studies reviewed indicated a steady increase in prescriptions, continuing a pre-existing upward trend, though a brief dip occurred during the initial 2020 lockdowns.

Which groups were most likely to be prescribed antidepressants?

The systematic review found that women and middle-aged adults were the primary demographics receiving antidepressant medications during the study period.

What types of antidepressants were most commonly tracked?

The research focused on common classes such as SSRIs, SNRIs, and tricyclic antidepressants, mirroring standard clinical practice in primary care.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional opinion. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Jones M et al. Antidepressant prescribing trends for adult patients in the UK and Ireland during the COVID-19 pandemic: systematic review. BJPsych Open. 2026 Mar 02. doi: 10.1192/bjo.2026.10990. PMID: 41766626.

Chua KP et al. Antidepressant dispensing to U.S. adolescents and young adults: 2016–2022. Pediatrics. 2024. doi: 10.1542/peds.2023-064245.

Miyamori D et al. Impact of COVID-19 on antidepressant prescription: a matched cohort study using the National insurance claims database in Japan. BMC Psychiatry. 2025 Jul 25;25(1):725. doi: 10.1186/s12888-025-07172-w.